Literature DB >> 1558966

Implantation and maintenance of functional human bone marrow in SCID-hu mice.

S Kyoizumi1, C M Baum, H Kaneshima, J M McCune, E J Yee, R Namikawa.   

Abstract

Human fetal bone fragments implanted in the immunodeficient C.B-17 scid/scid (SCID) mouse were shown to sustain active human hematopoiesis in vivo. Human progenitor cell activity was maintained for as long as 20 weeks after implantation and was associated with multilineage differentiation in the engrafted bone. Thus, the bone implants provided stem cells as well as the microenvironment requisite for their long-term maintenance and multilineage differentiation. Administration of human erythropoietin (Epo) stimulated human erythropoiesis in human bone implants. This animal model may facilitate direct analysis of a wide variety of physiologic and pathologic conditions of human bone marrow (BM) in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558966

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Hematopoietic stem cells.

Authors:  Robert G Hawley; Ali Ramezani; Teresa S Hawley
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  A clinically relevant SCID-hu in vivo model of human multiple myeloma.

Authors:  Pierfrancesco Tassone; Paola Neri; Daniel R Carrasco; Renate Burger; Victor S Goldmacher; Robert Fram; Vidit Munshi; Masood A Shammas; Laurence Catley; Gary S Jacob; Salvatore Venuta; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

4.  Relationship between spontaneous γH2AX foci formation and progenitor functions in circulating hematopoietic stem and progenitor cells among atomic-bomb survivors.

Authors:  Junko Kajimura; Seishi Kyoizumi; Yoshiko Kubo; Munechika Misumi; Kengo Yoshida; Tomonori Hayashi; Kazue Imai; Waka Ohishi; Kei Nakachi; Nan-Ping Weng; Lauren F Young; Jae-Hung Shieh; Malcolm A Moore; Marcel R M van den Brink; Yoichiro Kusunoki
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2016-04-19       Impact factor: 2.873

5.  Persistence of human vascular endothelium in experimental human prostate cancer bone tumors.

Authors:  J A Nemeth; J W Roberts; C M Mullins; M L Cher
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

6.  Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.

Authors:  Kuichun Zhu; Elvira Gerbino; Darrin M Beaupre; Paul A Mackley; Carlos Muro-Cacho; Craig Beam; Andrew D Hamilton; Mathias G Lichtenheld; William G Kerr; William Dalton; Melissa Alsina; Saïd M Sebti
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

7.  Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue.

Authors:  E Shtivelman; R Namikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

Review 8.  In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.

Authors:  T S Barry; B F Haynes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

9.  Age-associated changes in the differentiation potentials of human circulating hematopoietic progenitors to T- or NK-lineage cells.

Authors:  Seishi Kyoizumi; Yoshiko Kubo; Junko Kajimura; Kengo Yoshida; Kazue Imai; Tomonori Hayashi; Kei Nakachi; Lauren F Young; Malcolm A Moore; Marcel R M van den Brink; Yoichiro Kusunoki
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

10.  Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.

Authors:  D L Greiner; L D Shultz; J Yates; M C Appel; G Perdrizet; R M Hesselton; I Schweitzer; W G Beamer; K L Shultz; S C Pelsue
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.